Document is current

Article History

Received: 9 January 2026

Accepted: 13 February 2026

First Online: 27 February 2026

Declarations

:

: César Silva Ferreira has no conflicts of interest. Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Apogee, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Oruka, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, Sun Pharma, Takeda, and UCB. Tiago Torres is an Editorial Board member of Dermatology and Therapy. Tiago Torres was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

: In Portugal, ethical approval by a Research Ethics Committee is legally required for studies that fall under the scope of clinical research, as defined by Law No. 21/2014 of 16 April (Lei da Investigação Clínica). This law applies to interventional and non-interventional clinical studies conducted in human participants or involving individual health data. The present study consisted of an anonymous, voluntary, web-based survey of healthcare professionals and did not involve patients, clinical interventions, biological samples, or the collection of individual health data. As such, it does not meet the legal definition of a clinical study under Law No. 21/2014 and therefore does not require prior approval. The study was conducted in accordance with general ethical principles and the Declaration of Helsinki.